Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

552
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
552

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A blood-brain barrier model based on flexible tubes to tailor the biophysical and chemical environment for drug delivery testing.

Materials today. Bio·2026
Same author

Innovations in sensor technology and diagnostics.

Mikrochimica acta·2026
Same author

Neuroprotective Effects of Cerium Oxide Nanoparticles During Spaceflight.

Small science·2026
Same author

Polydopamine Nanoparticles as Label-Free Contrast Agents in Photoacoustic Imaging <i>In Vitro</i> and <i>In Vivo</i>.

ACS applied optical materials·2026
Same author

Smart Nanotechnologies for Multimodal Neuromodulation and Brain Interfacing.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Safety of posterolateral approach with a polished cemented stem and a modular dual mobility implant in patients over 75 years old.

Journal of orthopaedics·2026

Related Experiment Video

Updated: Jan 15, 2026

Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

39.2K

Polydopamine-Based Antioxidant Countermeasures Against Spaceflight-Induced Neurodegeneration.

Alessio Carmignani1, Attilio Marino1, Matteo Battaglini1

  • 1Smart Bio-Interfaces Istituto Italiano di Tecnologia Viale Rinaldo Piaggio 34 56025 Pontedera Italy.

Small Science
|January 14, 2026
PubMed
Summary
This summary is machine-generated.

Polydopamine nanoparticles (PDNPs) show promise in protecting neuron-like cells from spaceflight stressors like microgravity and radiation. This research suggests PDNPs could be a key countermeasure against space-induced neurodegeneration and related Earth-based conditions.

Keywords:
cosmic radiationmicrogravityneuroprotectionoxidative stresspolydopamine nanoparticles

More Related Videos

A Simple One-step Dissection Protocol for Whole-mount Preparation of Adult Drosophila Brains
09:53

A Simple One-step Dissection Protocol for Whole-mount Preparation of Adult Drosophila Brains

Published on: December 1, 2016

29.2K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

620

Related Experiment Videos

Last Updated: Jan 15, 2026

Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

39.2K
A Simple One-step Dissection Protocol for Whole-mount Preparation of Adult Drosophila Brains
09:53

A Simple One-step Dissection Protocol for Whole-mount Preparation of Adult Drosophila Brains

Published on: December 1, 2016

29.2K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

620

Area of Science:

  • Neuroscience
  • Space Biology
  • Nanotechnology

Background:

  • Spaceflight exposes astronauts to microgravity and cosmic radiation, leading to oxidative stress and neuronal dysfunction.
  • The central nervous system is highly susceptible to redox imbalance, necessitating countermeasures for long-duration missions.

Purpose of the Study:

  • To investigate the neuroprotective effects of polydopamine nanoparticles (PDNPs) against spaceflight-induced stressors.
  • To assess PDNPs' ability to mitigate oxidative stress and preserve neuronal function under simulated and actual space conditions.

Main Methods:

  • Neuron-like cells were treated with PDNPs and exposed to microgravity and radiation conditions (International Space Station and random positioning machine).
  • Transcriptomic analysis was performed to evaluate gene expression related to oxidative stress, cellular integrity, and dopamine metabolism.

Main Results:

  • PDNP treatment in-flight mitigated transcriptional alterations caused by space stressors, maintaining neuronal homeostasis.
  • Key antioxidant defense genes, mitochondrial function markers, and dopamine metabolism genes were stabilized in PDNP-treated neurons.
  • PDNPs demonstrated efficacy in protecting neuronal cells from combined spaceflight stressors.

Conclusions:

  • PDNPs show potential as a countermeasure for space-induced neurodegeneration.
  • Findings suggest translational applications for PDNPs in treating oxidative stress-related neurodegenerative diseases on Earth.